Threshold for epileptiform activity is elevated in prion knockout mice

Neuroscience

Volumn 179, Issue , 2011, Pages 56-61

  Ratte S ^a   Vreugdenhil, M ^a   Boult, J K R ^a   Patel, A ^a   Asante, E A ^b   Collinge, J ^b   Jefferys, J G R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bicuculline; Epilepsy; Hippocampus; Pentylenetetrazol; Prion; Zero magnesium

Indexed keywords

PRION PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EPILEPSY; EPILEPTIC DISCHARGE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

ANIMALS; BRAIN; CONVULSANTS; CREUTZFELDT-JAKOB SYNDROME; DISEASE MODELS, ANIMAL; EPILEPSY; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PRIONS;

EID: 79952619470     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.053     Document Type: Article

References (43)

1. Bingmann D., Speckmann E.-J. Actions of pentylenetetrazol (PTZ) on CA3 neurons in hippocampal slices of guinea pigs. Exp Brain Res 1986, 64:94-104.
2. Bragdon A.C., Taylor D.M., Wilson W.A. Potassium-induced epileptiform activity in area CA3 varies markedly along the septotemporal axis of the rat hippocampus. Brain Res 1986, 378:169-173.
3. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 1997, 146:104-112.
4. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582.
5. Colling S.B., Collinge J., Jefferys J.G.R. Hippocampal slices from prion protein null mice: disrupted Ca2+-activated K+ currents. Neurosci Lett 1996, 209:49-52.
6. Colling S.B., Khana M., Collinge J., Jefferys J.G.R. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 1997, 755:28-35.
7. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., Jefferys J.G.R. Prion protein is necessary for normal synaptic function. Nature 1994, 370:295-297.
8. Curtis D.R., Duggan A.W., Felix D., Johnston G.A. GABA, bicuculline and central inhibition. Nature 1970, 226:1222-1224.
9. Dreier J.P., Heinemann U. Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci Lett 1990, 119:68-70.
10. Fuhrmann M., Bittner T., Mitteregger G., Haider N., Moosmang S., Kretzschmar H., Herms J. Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons. J Neurochem 2006, 98:1876-1885.
11. Gilbert M., Racine R.J., Smith G.K. Epileptiform burst responses in ventral vs dorsal hippocampal slices. Brain Res 1985, 361:389-391.
12. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., Schurmann P., Windl O., Brose N., Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999, 19:8866-8875.
13. Herms J.W., Korte S., Gall S., Schneider I., Dunker S., Kretzschmar H.A. Altered intracellular calcium homeostasis in cerebellar granule cells of prion protein-deficient mice. J Neurochem 2000, 75:1487-1492.
14. Herms J.W., Kretzchmar H.A., Titz S., Keller B.U. Patch-clamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice. Eur J Neurosci 1995, 7:2508-2512.
15. Herms J.W., Tings T., Dunker S., Kretzschmar H.A. Prion protein affects Ca2+-activated K+ currents in cerebellar Purkinje cells. Neurobiol Dis 2001, 8:324-330.
16. Herron C.E., Williamson R., Collingridge G.L. A selective N-methyl-d-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci Lett 1985, 61:255-260.
17. Hill A.F., Antoniou M., Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999, 80:11-14.
18. Huang R.Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABAA) receptors: mechanism and site of action. J Pharmacol Exp Ther 2001, 298:986-995.
19. Johnson S.W., Seutin V. Bicuculline methiodide potentiates NMDA-dependent burst firing in rat dopamine neurons by blocking apamin-sensitive Ca2+-activated K+ currents. Neurosci Lett 1997, 231:13-16.
20. Khosravani H., Zhang Y., Tsutsui S., Hameed S., Altier C., Hamid J., Chen L., Villemaire M., Ali Z., Jirik F.R., Zamponi G.W. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008, 181:551-565.
21. Leweke F.M., Louvel J., Rausche G., Heinemann U. Effects of pentetrazol on neuronal activity and on extracellular calcium concentration in rat hippocampal slices. Epilepsy Res 1990, 6:187-198.
22. MacDonald R.L., Barker J.L. Specific antagonism of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: a common mode of convulsant action. Neurology 1978, 28:325-330.
23. Magnusson K.R. The aging of the NMDA receptor complex. Front Biosci 1998, 3:e70-e80.
24. Mallucci G., Collinge J. Update on Creutzfeldt-Jakob disease. Curr Opin Neurol 2004, 17:641-647.
25. Mallucci G., Collinge J. Rational targeting for prion therapeutics. Nat Rev Neurosci 2005, 6:23-34.
26. Mallucci G.R., Ratte S., Asante E.A., Linehan J., Gowland I., Jefferys J.G.R., Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002, 21:202-210.
27. Millan M.H., Obrenovitch T.P., Sarna G.S., Lok S.Y., Symon L., Meldrum B.S. Changes in rat brain extracellular glutamate concentration during seizures induced by systemic picrotoxin or focal bicuculline injection: an in vivo dialysis study with on-line enzymatic detection. Epilepsy Res 1991, 9:86-91.
28. Mody I., Lambert J.D., Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987, 57:869-888.
29. Neufeld M.Y., Talianski-Aronov A., Soffer D., Korczyn A.D. Generalized convulsive status epilepticus in Creutzfeldt-Jakob disease. Seizure 2003, 12:403-405.
30. Omrani A., Fathollahi Y., Almasi M., Semnanian S., Mohammad S., Firoozabadi P. Contribution of ionotropic glutamate receptors and voltage-dependent calcium channels to the potentiation phenomenon induced by transient pentylenetetrazol in the CA1 region of rat hippocampal slices. Brain Res 2003, 959:173-181.
31. Parry J., Tuch P., Knezevic W., Fabian V. Creutzfeldt-Jakob syndrome presenting as epilepsia partialis continua. J Clin Neurosci 2001, 8:266-268.
32. Piredda S., Yonekawa W., Whittingham T.S., Kupferberg H.J. Potassium, pentylenetetrazol, and anticonvulsants in mouse hippocampal slices. Epilepsia 1985, 26:167-174.
33. Powell A.D., Toescu E.C., Collinge J., Jefferys J.G.R. Alterations in Ca2+-buffering in prion-null mice: association with reduced afterhyperpolarizations in CA1 hippocampal neurons. J Neurosci 2008, 28:3877-3886.
34. Rees J.H., Smith S.J., Kullmann D.M., Hirsch N.P., Howard R.S. Creutzfeldt-Jakob disease presenting as complex partial status epilepticus: a report of two cases. J Neurol Neurosurg Psychiatry 1999, 66:406-407.
35. Schneiderman J.H., MacDonald J.F. Effects of reduced magnesium on hippocampal synchrony. Brain Res 1987, 410:174-178.
36. Schwartzkroin P.A., Prince D.A. Cellular and field potential properties of epileptogenic hippocampal slices. Brain Res 1978, 147:117-130.
37. Stanton P.K., Jones R.S., Mody I., Heinemann U. Epileptiform activity induced by lowering extracellular Mg2+ in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-d-aspartate. Epilepsy Res 1987, 1:53-62.
38. Tancredi V., Avoli M., Hwa G.G. Low-magnesium epilepsy in rat hippocampal slices: inhibitory postsynaptic potentials in the CA1 subfield. Neurosci Lett 1988, 89:293-298.
39. Tang L.H., Aizenman E. The modulation of N-methyl-d-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitro. J Physiol 1993, 465:303-323.
40. Vassallo N., Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003, 86:538-544.
41. Walz R., Amaral O.B., Rockenbach I.C., Roesler R., Izquierdo I., Cavalheiro E.A., Martins V.R., Brentani R.R. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999, 40:1679-1682.
42. Walz R., Castro R.M., Velasco T.R., Alexandre V., Lopes M.H., Leite J.P., Santos A.C., Assirati J.A., Wichert-Ana L., Terra-Bustamante V.C., Bianchin M.M., Maciag P.C., Ribeiro K.B., Guarnieri R., Araujo D., Cabalero O., Moura R., Salim A.C., Kindlmann K., Landemberger M.C., Marques W., Fernandes R.M., Serafini L.N., Machado H.R., Carlotti C.G., Brentani R.R., Sakamoto A.C., Martins V.R. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003, 61:1204-1210.
43. Zhao X., Rosenke R., Kronemann D., Brim B., Das S.R., Dunah A.W., Magnusson K.R. The effects of aging on N-methyl-d-aspartate receptor subunits in the synaptic membrane and relationships to long-term spatial memory. Neuroscience 2009, 162:933-945.